GR3029450T3 - Triazospirodecanone-methyl-chromans for the treatment of central nervous system illnesses - Google Patents

Triazospirodecanone-methyl-chromans for the treatment of central nervous system illnesses

Info

Publication number
GR3029450T3
GR3029450T3 GR990400535T GR990400535T GR3029450T3 GR 3029450 T3 GR3029450 T3 GR 3029450T3 GR 990400535 T GR990400535 T GR 990400535T GR 990400535 T GR990400535 T GR 990400535T GR 3029450 T3 GR3029450 T3 GR 3029450T3
Authority
GR
Greece
Prior art keywords
nervous system
central nervous
methyl
triazospirodecanone
chromans
Prior art date
Application number
GR990400535T
Other languages
Greek (el)
English (en)
Inventor
Hans-Georg Dr Heine
Rudolf Dr Schohe-Loop
Thomas Dr Glaser
Vry Jean Marie Viktor Dr De
Wolfgang Dr Dompert
Henning Dr Sommermeyer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of GR3029450T3 publication Critical patent/GR3029450T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR990400535T 1991-10-28 1999-02-19 Triazospirodecanone-methyl-chromans for the treatment of central nervous system illnesses GR3029450T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4135473A DE4135473A1 (de) 1991-10-28 1991-10-28 Triazaspirodecanon-methylchromane

Publications (1)

Publication Number Publication Date
GR3029450T3 true GR3029450T3 (en) 1999-05-28

Family

ID=6443565

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400535T GR3029450T3 (en) 1991-10-28 1999-02-19 Triazospirodecanone-methyl-chromans for the treatment of central nervous system illnesses

Country Status (19)

Country Link
US (1) US6060482A (enExample)
EP (1) EP0539803B1 (enExample)
JP (1) JP3257708B2 (enExample)
KR (1) KR930007945A (enExample)
AT (1) ATE175414T1 (enExample)
AU (1) AU650792B2 (enExample)
CA (1) CA2081256A1 (enExample)
CZ (1) CZ322492A3 (enExample)
DE (2) DE4135473A1 (enExample)
DK (1) DK0539803T3 (enExample)
ES (1) ES2125879T3 (enExample)
FI (1) FI924848A7 (enExample)
GR (1) GR3029450T3 (enExample)
HU (1) HUT64068A (enExample)
IL (1) IL103546A0 (enExample)
MX (1) MX9205869A (enExample)
NO (1) NO923974L (enExample)
TW (1) TW208010B (enExample)
ZA (1) ZA928290B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives
US6686370B2 (en) * 1999-12-06 2004-02-03 Euro-Celtique S.A. Triazospiro compounds having nociceptin receptor affinity
WO2003040382A1 (en) * 2001-11-09 2003-05-15 Kaneka Corporation Process for producing optically active chroman derivative and intermediate
US6995168B2 (en) 2002-05-31 2006-02-07 Euro-Celtique S.A. Triazaspiro compounds useful for treating or preventing pain
AU2003268512A1 (en) * 2002-09-09 2004-03-29 Janssen Pharmaceutica N.V. Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
US20070229303A1 (en) * 2003-10-16 2007-10-04 Collier Willliam R Fluid Level Detector and Alarm Apparatus
US20060178390A1 (en) * 2004-08-02 2006-08-10 Alfonzo Jordan 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
CN101622254B (zh) * 2006-11-28 2013-05-29 詹森药业有限公司 3-(3-氨基-2-(r)-羟基-丙基)-1-(4-氟-苯基)-8-(8-甲基-萘-1-基甲基)-1,3,8-三氮杂-螺[4.5]癸烷-4-酮的盐
MX2009011006A (es) * 2007-04-09 2009-11-02 Janssen Pharmaceutica Nv Derivados de 1,3,8-trisustituido-1,3,8-triaza-espiro[4.5]decano-4- ona como ligandos del receptor de orl-1 para el tratamiento de ansiedad y depresion.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826835A (en) * 1971-01-08 1974-07-30 Ciba Geigy Corp 8-benzofurylmethyl-1,3,8-triazaspiro(4,5)decanes as neuroleptics
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4826848A (en) * 1985-04-15 1989-05-02 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4957928A (en) * 1986-06-26 1990-09-18 Ciba-Geigy Corporation Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE3831888A1 (de) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg Arzneimittel zur behandlung von apoplexia cerebri
DE4039631A1 (de) * 1990-12-12 1992-06-17 Troponwerke Gmbh & Co Kg Neuroprotektive kombination

Also Published As

Publication number Publication date
US6060482A (en) 2000-05-09
KR930007945A (ko) 1993-05-20
AU2626592A (en) 1993-04-29
ES2125879T3 (es) 1999-03-16
MX9205869A (es) 1993-04-01
CA2081256A1 (en) 1993-04-29
HUT64068A (en) 1993-11-29
FI924848A0 (fi) 1992-10-26
NO923974L (no) 1993-04-29
NO923974D0 (no) 1992-10-13
EP0539803A1 (de) 1993-05-05
JP3257708B2 (ja) 2002-02-18
ZA928290B (en) 1993-05-04
DE4135473A1 (de) 1993-04-29
EP0539803B1 (de) 1999-01-07
DE59209607D1 (de) 1999-02-18
FI924848A7 (fi) 1993-04-29
HU9203382D0 (en) 1993-01-28
CZ322492A3 (en) 1993-07-14
JPH05222040A (ja) 1993-08-31
DK0539803T3 (da) 1999-08-30
AU650792B2 (en) 1994-06-30
ATE175414T1 (de) 1999-01-15
TW208010B (enExample) 1993-06-21
IL103546A0 (en) 1993-03-15

Similar Documents

Publication Publication Date Title
FI925549A0 (fi) Nya azaheterocyklylmetyl-kromaner
FR2672818B1 (fr) Procede de production d'oxygene par adsorption.
IL109578A (en) Nor-bile acid derivatives processes for their preparation and the use of these compounds as medicaments
AU2626492A (en) 2- aminomethyl-chromans
AU5799294A (en) Isoxazole-4-carboxamides and hydroxy-alkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
AU2294788A (en) Apparatus for the intensive, controlled production of microorganisms by photosynthesis
HU210714A9 (en) Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals
FI893262A0 (fi) Nya disfosfonsyraderivat, foerfarande foer deras framstaellning och laekemedel innehaollande dessa foereningar.
ZA928643B (en) The resolution of 5-methyltetrahydrofolic acid
TW208010B (enExample)
HU9301366D0 (en) Benzo-pyridone derivatives and pyrido-pyridone ones substituted with sulfonyl-benzyl group
GB9319732D0 (en) Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety
ATE155478T1 (de) 4,13-dioxabicyclo(8.2.1>tridecenon-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0486386A3 (en) Novel derivatives of n-benzoylproline, process for their preparation and drugs containing them
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
NZ248794A (en) 3-carboxy-(and phosphonoxy-)alkatriene-substituted chromene derivatives and medicaments
AU2993692A (en) Piperidylmethyl-substituted chroman derivatives
DE59408453D1 (de) Pyrido-pyrimidindione, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ITMI920460A0 (it) Procedimento per produrre l-lisina mediante fermentazione
DE68906049D1 (de) Benzocyclohexan- und benzocycloheptan-derivate und deren salze, verfahren und zwischenprodukte zu deren herstellung, deren verwendung als heilmittel und diese enthaltende zusammensetzungen.
BR9401523A (pt) Sistema de orif/icios m/ultiplos de alimentação de vidro
EP0551844A3 (enExample)
DE3372970D1 (en) 6-alpha-methyl-prednisolone derivatives, their preparation and utilization
DE3577183D1 (de) Verwendung eines diamins zur herstellung eines erythrozyten-weichmachers.
PT80360B (en) (6,11-dihydro-11-oxidibenz<b,e>oxepinyl)pentanols a process and intermediates for their preparation and their use as medicaments